D. Brun

发表

Effect of hyperchylomicronemia on the measurement of hemoglobin.

S. Moorjani, P. Lupien, C. Gagné, 1977, American journal of clinical pathology.

Effectiveness of 3-hydroxy-3-methylglutaric acid in familial hypercholesterolaemia.

S. Moorjani, P. Lupien, D. Brun, 1973, Lancet.

Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia.

S. Moorjani, P. Lupien, C. Gagné, 1986, Metabolism: clinical and experimental.

Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women.

S. Moorjani, P. Lupien, C. Gagné, 1979, Atherosclerosis.

Effects of 3‐Hydroxy‐3‐methylglutaric Acid on Plasma and Low‐Density Lipoprotein Cholesterol Levels in Familial Hypercholesterolemia

P. Bielmann, S. Moorjani, P. Lupien, 1979, Journal of clinical pharmacology.

Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.

P. Julien, S. Moorjani, P. Lupien, 1991, The Canadian journal of cardiology.

Removal of Cholesterol from Blood by Affinity Binding to Heparin-Agarose: Evaluation on Treatment in Homozygous Familial Hypercholesterolemia

S. Moorjani, P. Lupien, C. Gagné, 1980, Pediatric Research.

Homozygous Familial Hypercholesterolemia among French Canadians in Quebec Province

M. Lambert, J. Davignon, P. Lupien, 1989, Arteriosclerosis.

Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide.

F. Labrie, S. Moorjani, A. Bélanger, 1988, The Journal of clinical endocrinology and metabolism.

Influence of diets containing cow's milk or soy protein beverage on plasma lipids in children with familial hypercholesterolemia.

S. Moorjani, D. Laurin, P. Lupien, 1992, Journal of the American College of Nutrition.

Articular manifestations of familial hypercholesterolaemia.

S. Moorjani, P. Lupien, C. Gagné, 1985, Annals of the rheumatic diseases.

Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Québec

M. Hayden, P. Julien, J. Bergeron, 1992, Clinical genetics.

Effect of obesity on plasma triglyceride levels in familial lipoprotein lipase deficiency

J. Després, D. Gaudet, M. Vohl, 1995 .

Dose‐response to tibric acid: A new hypolipidemic drug in type IV hyperlipoproteinemia

P. Bielmann, S. Moorjani, P. Lupien, 1975, Clinical pharmacology and therapeutics.

Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia.

S. Moorjani, D. Laurin, P. Lupien, 1991, The American journal of clinical nutrition.

Founder effect in familial hyperchylomicronemia among French Canadians of Quebec.

P. Julien, P. Lupien, C. Gagné, 1991, Human heredity.

Hypertriglyceridemia and Lower LDL Cholesterol Concentration in Relation to Apolipoprotein E Phenotypes in Myotonic Dystrophy

J. Morissette, D. Gaudet, C. Laberge, 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Beta blockers and their effects on lipoproteins, phospholipids, apoproteins A and B, in whole plasma and the different fractions.

P. Bielmann, P. Lupien, C. Gagné, 1982, International journal of clinical pharmacology, therapy, and toxicology.

LONG-TERM TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA WITH 3-HYDROXY-3-METHYLGLUTARIC ACID

S. Moorjani, P. Lupien, D. Brun, 1978, The Lancet.

Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma.

F. Labrie, S. Moorjani, A. Bélanger, 1987, Metabolism: clinical and experimental.

Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia

M. Lambert, P. Lupien, S. Moorjani, 1993, The Lancet.

Probucol and high-density-lipoprotein cholesterol.

S. Moorjani, P. Lupien, C. Gagné, 1980, Canadian Medical Association journal.

[Double-blind clinical and echocardiographic study of oral enoximone versus placebo in severe cardiac insufficiency].

G. Jondeau, O. Dubourg, J. Bourdarias, 1992, Archives des maladies du coeur et des vaisseaux.

1.P.178 Effect of atorvastatin on serum levels of lipoproteins in French Canadians with homozygous or compound heterozygous familial hypercholesterolemia

D. Gaudet, P. Couture, J. Bergeron, 1997 .

Beneficial effects of the calcium antagonist isradipine on apolipoproteins in hypertensive patients.

Y. Lacourciére, L. Poirier, C. Gagné, 1991, American Journal of Hypertension.

Homozygous familial hypercholesterolaemia

S. Moorjani, P. Lupien, C. Gagné, 1994, The Lancet.